Alejandra
Otero Ferreiro
Hospital Virgen de la Arrixaca
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (10)
2024
2023
-
Best practices during COVID-19 pandemic in solid organ transplant programs in Spain
Transplantation Reviews, Vol. 37, Núm. 1
-
Effectiveness and safety of once-daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study
Clinical Transplantation, Vol. 37, Núm. 12
2022
-
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019
Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050
2021
-
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155
2017
-
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Transplant International, Vol. 30, Núm. 10, pp. 1041-1050
2015
-
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain
Liver Transplantation, Vol. 21, Núm. 8, pp. 1056-1065
2014
-
"very early" intrahepatic cholangiocarcinoma in cirrhotic patients: Should liver transplantation be reconsidered in these patients?
American Journal of Transplantation, Vol. 14, Núm. 3, pp. 660-667
-
Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: A spanish matched cohort multicenter study
Annals of Surgery, Vol. 259, Núm. 5, pp. 944-952